Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 462Gynecologic 246Breast 153CNS 90Head & Neck 80Genitourinary 77Gastrointestinal 65Other solid neoplasm 57Lymphoid 54Tumor-Agnostic 51Sarcoma 36Dermatologic 28Other hematologic neoplasm 19Myeloid 7Classical hematology 7Endocrine 5NET 4Plasma cell 3Other neoplasm 1Other 1

Conditions

Xerostomia 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Mucositis 1Head and Neck Neoplasms 1

Interventions

Exercise 15Metformin 14Surveys and Questionnaires 12Radiotherapy 9Methods 7naloxegol 6Nutrition Assessment 6Counseling 6alvimopan 5Resistance Training 5Psychiatric Rehabilitation 5Exenatide 5Early Intervention, Educational 5Diet Therapy 5Diet 5Sugars 4Mindfulness-Based Stress Reduction 4Injections 4Fibroblast Growth Factor 7 4Educational Status 4Drug Therapy 4Vitamin D 3Therapeutics 3Standard of Care 3Liraglutide 3Interviews as Topic 3Fentanyl 3Cryotherapy 3Cognitive Behavioral Therapy 3Cisplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carboplatin × Other × Clear all
NCT00095927 2017-01-04

Randomized Amifostine For SCCHN

Dana-Farber Cancer Institute

Phase 2 Completed
58 enrolled
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Radiation Injuries, Xerostomia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡